Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS

K. Henry, H. Cantrill, Courtney V Fletcher, B. J. Chinnock, H. H. Balfour

Research output: Contribution to journalArticle

163 Citations (Scopus)

Abstract

A patient with acquired immune deficiency syndrome with bilateral cytomegalovirus retinitis was treated with intravitreal 200-ug/0.1-ml doses of ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl]guanine). The ganciclovir serum and intravitreal concentrations were measured with an enzyme-linked immunosorbent assay and pharmacokinetic factors were determined. There was no evidence of systemic absorption of ganciclovir from the eye. The elimination half-life of ganciclovir from the vitreous was estimated to be 13.3 hours. The intravitreal concentration remained above the ID50 of cytomegalovirus for approximately 62 hours after a single injection. Clinically, the patient retained useful vision in his right eye for three months. A total of 28 intravitreal injections were given on an outpatient basis under topical anesthesia and were well tolerated. There was no evidence of retinal toxicity from the drug.

Original languageEnglish (US)
Pages (from-to)17-23
Number of pages7
JournalAmerican journal of ophthalmology
Volume103
Issue number1
DOIs
StatePublished - Jan 1 1987
Externally publishedYes

Fingerprint

Cytomegalovirus Retinitis
Ganciclovir
Guanine
Acquired Immunodeficiency Syndrome
Intravitreal Injections
Drug-Related Side Effects and Adverse Reactions
Cytomegalovirus
Half-Life
Outpatients
Anesthesia
Pharmacokinetics
Enzyme-Linked Immunosorbent Assay
Injections
Serum

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. / Henry, K.; Cantrill, H.; Fletcher, Courtney V; Chinnock, B. J.; Balfour, H. H.

In: American journal of ophthalmology, Vol. 103, No. 1, 01.01.1987, p. 17-23.

Research output: Contribution to journalArticle

@article{27b1ec7f2162406291b2690f98581d26,
title = "Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS",
abstract = "A patient with acquired immune deficiency syndrome with bilateral cytomegalovirus retinitis was treated with intravitreal 200-ug/0.1-ml doses of ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl]guanine). The ganciclovir serum and intravitreal concentrations were measured with an enzyme-linked immunosorbent assay and pharmacokinetic factors were determined. There was no evidence of systemic absorption of ganciclovir from the eye. The elimination half-life of ganciclovir from the vitreous was estimated to be 13.3 hours. The intravitreal concentration remained above the ID50 of cytomegalovirus for approximately 62 hours after a single injection. Clinically, the patient retained useful vision in his right eye for three months. A total of 28 intravitreal injections were given on an outpatient basis under topical anesthesia and were well tolerated. There was no evidence of retinal toxicity from the drug.",
author = "K. Henry and H. Cantrill and Fletcher, {Courtney V} and Chinnock, {B. J.} and Balfour, {H. H.}",
year = "1987",
month = "1",
day = "1",
doi = "10.1016/S0002-9394(14)74163-7",
language = "English (US)",
volume = "103",
pages = "17--23",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS

AU - Henry, K.

AU - Cantrill, H.

AU - Fletcher, Courtney V

AU - Chinnock, B. J.

AU - Balfour, H. H.

PY - 1987/1/1

Y1 - 1987/1/1

N2 - A patient with acquired immune deficiency syndrome with bilateral cytomegalovirus retinitis was treated with intravitreal 200-ug/0.1-ml doses of ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl]guanine). The ganciclovir serum and intravitreal concentrations were measured with an enzyme-linked immunosorbent assay and pharmacokinetic factors were determined. There was no evidence of systemic absorption of ganciclovir from the eye. The elimination half-life of ganciclovir from the vitreous was estimated to be 13.3 hours. The intravitreal concentration remained above the ID50 of cytomegalovirus for approximately 62 hours after a single injection. Clinically, the patient retained useful vision in his right eye for three months. A total of 28 intravitreal injections were given on an outpatient basis under topical anesthesia and were well tolerated. There was no evidence of retinal toxicity from the drug.

AB - A patient with acquired immune deficiency syndrome with bilateral cytomegalovirus retinitis was treated with intravitreal 200-ug/0.1-ml doses of ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl]guanine). The ganciclovir serum and intravitreal concentrations were measured with an enzyme-linked immunosorbent assay and pharmacokinetic factors were determined. There was no evidence of systemic absorption of ganciclovir from the eye. The elimination half-life of ganciclovir from the vitreous was estimated to be 13.3 hours. The intravitreal concentration remained above the ID50 of cytomegalovirus for approximately 62 hours after a single injection. Clinically, the patient retained useful vision in his right eye for three months. A total of 28 intravitreal injections were given on an outpatient basis under topical anesthesia and were well tolerated. There was no evidence of retinal toxicity from the drug.

UR - http://www.scopus.com/inward/record.url?scp=0023205155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023205155&partnerID=8YFLogxK

U2 - 10.1016/S0002-9394(14)74163-7

DO - 10.1016/S0002-9394(14)74163-7

M3 - Article

VL - 103

SP - 17

EP - 23

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 1

ER -